Acevector IPO Day 4: GMP ₹2
Welcome back to our daily Acevector IPO update! We’ve officially reached Day 4 of the subscription period for Acevector’s mainboard IPO on the NSE, and it’s been an interesting journey so far. As the IPO window is set to close on September 29th, investors are making their final decisions. Let’s dive into the latest subscription numbers and Grey Market Premium (GMP) to see where things stand.
| Date | GMP | Est. Listing |
|---|---|---|
| 25 Sep | +₹2 | ₹34 |
Subscription Status
As of Day 4, the subscription figures for Acevector IPO are showing 0x across all categories: Retail, NII (Non-Institutional Investors), and QIB (Qualified Institutional Buyers). The total subscription also stands at 0x. This is quite unusual, especially on Day 4 of a mainboard IPO. Typically, by this stage, we’d expect to see at least some level of interest, even if it’s modest. The complete absence of subscriptions in all segments can indicate a few things. It might mean investors are waiting for the very last day to apply, perhaps to gauge the final GMP or to manage their cash flow. Alternatively, it could suggest a lack of initial buzz or that the market is adopting a wait-and-watch approach. For NIIs and QIBs, who often apply in larger numbers and can significantly sway subscription levels, their silence is particularly noteworthy. It could be that they are evaluating the company’s fundamentals more closely or are holding back for other investment opportunities. We’ll need to see a substantial surge in the final day or two to change this picture.
| Category | Subscription | Progress |
|---|---|---|
| Retail | 4.83x | |
| NII / HNI | 8.53x | |
| QIB | 3.42x | |
| Total | 8.53x |
GMP Update
Moving on to the Grey Market Premium (GMP), Acevector IPO’s GMP remains steady at ₹2. This is the same as yesterday’s figure, indicating no significant shift in market sentiment regarding the potential listing gains. The issue price for Acevector IPO is ₹32. With a GMP of ₹2, the expected listing price is around ₹34 (Issue Price + GMP). While a positive GMP is always encouraging, a ₹2 GMP is quite low. It suggests that the market isn’t anticipating substantial immediate gains on listing. This could be a reflection of the current subscription levels or the overall market sentiment towards new listings. For investors looking for quick profits, this low GMP might not be as appealing. However, it’s important to remember that GMP is an unofficial indicator and can fluctuate. We’ve seen GMPs change dramatically in the final hours of subscription before.
Should You Apply?
The decision to apply for the Acevector IPO hinges on your investment strategy and risk appetite. On one hand, the current subscription numbers are a clear concern. A 0x subscription across all categories by Day 4 is not a typical sign of strong demand. This could translate into a subdued listing if the trend continues. The low GMP of ₹2 further supports the idea that significant listing gains aren’t currently priced in by the grey market. However, that said, the IPO period is not over yet, and Day 5 can sometimes bring unexpected surges in applications, especially from retail investors who often apply on the last day. The lot size is 468 shares, so each lot would require an investment of ₹15,000 (468 shares * ₹32 issue price). If you’re a long-term investor looking at Acevector’s business fundamentals and its future prospects, you might still consider applying. For those seeking quick listing gains, the current data suggests caution. As always, it’s wise to consult with SEBI registered investment advisors for personalized guidance. Remember, investing in IPOs involves market risks.